|

Hemay005 Clinical Trials

1 actively recruiting trial

Also known as: Hemay005 tablet

Pipeline

Phase 1: 1

Top Sponsors

  • Ganzhou Hemay Pharmaceutical Co., Ltd1

Indications

  • Liver Disease1
  • Psoriasis1

Other1 trial

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.